Mitsubishi Tanabe Pharma Corporation Reports Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2017; Revises Earnings Guidance for the Full Year Ending March 31, 2018; Provides Earnings Guidance for the Second Half of Fiscal Year 2017
For the quarter, the company reported revenue of JPY 105.6 billion against JPY 98.6 billion a year ago. Core operating profit was JPY 17.7 billion against JPY 18.9 billion a year ago. Operating profit was JPY 15.8 billion against JPY 18.6 billion a year ago. Profit before tax was JPY 15.5 billion against JPY 19.1 billion a year ago. Net profit attributable to owners of the company was JPY 12.8 billion against JPY 14.3 billion a year ago.
For the full year ending March 31, 2018, the company now expects revenue of JPY 433,000 million, core operating profit of JPY 80,000 million, operating profit of JPY 81,000 million, profit before tax of JPY 82,000 million, gross profit of JPY 263.5 billion, and profit attributable to owners of the company of JPY 63,500 million compared to previous forecast of revenue of JPY 441 billion, core operating profit of JPY 90 billion, operating profit of JPY 90 billion, profit before tax of JPY 91 billion, gross profit of JPY 271.5 billion, and profit attributable to owners of the company of JPY 71.5 billion. The company expects investment in property, plant and equipment of JPY 6.9 billion.
For the second half of fiscal 2017, the company expects revenue of 219.6 billion, core operating profit of JPY 40.2 billion, operating profit of JPY 44.1 billion, profit before tax of JPY 44.4 billion, gross profit of JPY 134.6 billion, and profit attributable to owners of the company of JPY 33.6 billion.